Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead
dc.contributor.author | Marin, Gustavo H. | |
dc.contributor.author | Giangreco, Lucia | |
dc.contributor.author | Dorati, Cristian | |
dc.contributor.author | Mordujovich, Perla | |
dc.contributor.author | Boni, Silvia | |
dc.contributor.author | Mantilla-Ponte, Hilda | |
dc.contributor.author | Alfonso Arvez, Ma Jose | |
dc.contributor.author | Lopez Pena, Monica | |
dc.contributor.author | Aldunate Gonzalez, Ma Francisca | |
dc.contributor.author | Fung, Shing Mi Ching | |
dc.contributor.author | Barcelona, Laura | |
dc.contributor.author | Campana, Laura | |
dc.contributor.author | Vaquero Orellana, Alejandra | |
dc.contributor.author | Orjuela Rodriguez, Tatiana | |
dc.contributor.author | Gines Cantero, Larissa | |
dc.contributor.author | Villar, Rosa A. | |
dc.contributor.author | Sandoval Fuentes, Nicole | |
dc.contributor.author | Melero, Emiliano | |
dc.contributor.author | Marin-Piva, Hugo | |
dc.contributor.author | Soler, Gisela | |
dc.contributor.author | Gabriel, Fernanda | |
dc.contributor.author | Pineda Velandia, Laura | |
dc.contributor.author | Ojeda Florentin, Cinthia | |
dc.contributor.author | Risso Patron, Soledad | |
dc.contributor.author | Ortiz Rivas, Mariela | |
dc.contributor.author | Mendoza Benitez, Carolina | |
dc.contributor.author | Mellado, Rosemarie | |
dc.contributor.author | Ivanovska, Verica | |
dc.contributor.author | Muller, Arno | |
dc.contributor.author | Rojas, Robin | |
dc.contributor.author | Castro, Jose Luis | |
dc.date.accessioned | 2025-01-20T21:08:53Z | |
dc.date.available | 2025-01-20T21:08:53Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, POI AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like "Reserve," there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1177/21501319221082346 | |
dc.identifier.eissn | 2150-1327 | |
dc.identifier.issn | 2150-1319 | |
dc.identifier.uri | https://doi.org/10.1177/21501319221082346 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/93499 | |
dc.identifier.wosid | WOS:000786489400001 | |
dc.language.iso | en | |
dc.revista | Journal of primary care and community health | |
dc.rights | acceso restringido | |
dc.subject | antimicrobial | |
dc.subject | consumption | |
dc.subject | data source | |
dc.subject | information | |
dc.subject | GLASS | |
dc.subject | Latin America | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead | |
dc.type | artículo | |
dc.volumen | 13 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |